Literature DB >> 25209027

Genetics of opiate addiction.

Brian Reed1, Eduardo R Butelman, Vadim Yuferov, Matthew Randesi, Mary Jeanne Kreek.   

Abstract

Addiction to MOP-r agonists such as heroin (and also addiction to prescription opioids) has reemerged as an epidemic in the twenty first century, causing massive morbidity. Understanding the genetics contributing to susceptibility to this disease is crucial for the identification of novel therapeutic targets, and also for discovery of genetic markers which would indicate relative protection or vulnerability from addiction, and relative responsiveness to pharmacotherapy. This information could thus eventually inform clinical practice. In this review, we focus primarily on association studies of heroin and opiate addiction, and further describe the studies which have been replicated in this field, and are thus more likely to be useful for translational efforts.

Entities:  

Mesh:

Year:  2014        PMID: 25209027     DOI: 10.1007/s11920-014-0504-6

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  85 in total

1.  Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Authors:  Ying Zhang; Danxin Wang; Andrew D Johnson; Audrey C Papp; Wolfgang Sadée
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

2.  Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the Mu opioid receptor gene.

Authors:  Gavin Bart; K Steven LaForge; Lisa Borg; Charles Lilly; Ann Ho; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2006-06-21       Impact factor: 7.853

3.  The aldehyde dehydrogenase 2 gene is associated with heroin dependence.

Authors:  Tzu-Yun Wang; Sheng-Yu Lee; Shiou-Lan Chen; Shih-Heng Chen; Chun-Hsien Chu; San-Yuan Huang; Nian-Sheng Tzeng; Yun-Hsuan Chang; Chen-Lin Wang; I Hui Lee; Tzung Lieh Yeh; Yen Kuang Yang; Ru-Band Lu
Journal:  Drug Alcohol Depend       Date:  2011-07-01       Impact factor: 4.492

4.  Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype.

Authors:  O Levran; E Peles; M Randesi; Y Li; J Rotrosen; J Ott; M Adelson; M J Kreek
Journal:  Psychoneuroendocrinology       Date:  2014-04-06       Impact factor: 4.905

5.  Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study.

Authors:  R Horowitz; M Kotler; E Shufman; S Aharoni; I Kremer; H Cohen; R P Ebstein
Journal:  Am J Med Genet       Date:  2000-10-09

6.  The proenkephalin gene (PENK) and opioid dependence.

Authors:  D E Comings; H Blake; G Dietz; R Gade-Andavolu; R S Legro; G Saucier; P Johnson; R Verde; J P MacMurray
Journal:  Neuroreport       Date:  1999-04-06       Impact factor: 1.837

7.  Mu-opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic-pituitary-adrenal axis adrenocorticotropic hormone stress response to metyrapone.

Authors:  Elizabeth Ducat; Brenda Ray; Gavin Bart; Yoshie Umemura; Jack Varon; Ann Ho; Mary Jeanne Kreek
Journal:  Addict Biol       Date:  2011-04-20       Impact factor: 4.280

8.  The influence of GABRA2, childhood trauma, and their interaction on alcohol, heroin, and cocaine dependence.

Authors:  Mary-Anne Enoch; Colin A Hodgkinson; Qiaoping Yuan; Pei-Hong Shen; David Goldman; Alec Roy
Journal:  Biol Psychiatry       Date:  2010-01-01       Impact factor: 13.382

9.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Involvement of dynorphin and kappa opioid receptor in yohimbine-induced reinstatement of heroin seeking in rats.

Authors:  Yan Zhou; Francesco Leri; Stephanie L Grella; Jane V Aldrich; Mary Jeanne Kreek
Journal:  Synapse       Date:  2013-02-26       Impact factor: 2.562

View more
  15 in total

Review 1.  Emergence of sex differences in the development of substance use and abuse during adolescence.

Authors:  Cynthia Kuhn
Journal:  Pharmacol Ther       Date:  2015-06-03       Impact factor: 12.310

2.  Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.

Authors:  Caroline A Browne; Rebecca L Erickson; Julie A Blendy; Irwin Lucki
Journal:  Neuropharmacology       Date:  2017-02-07       Impact factor: 5.250

3.  Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice.

Authors:  Jia Zhan; Chloe J Jordan; Guo-Hua Bi; Xiang-Hu He; Eliot L Gardner; Yan-Lin Wang; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2018-08-20       Impact factor: 5.250

Review 4.  Endogenous Opioids at the Intersection of Opioid Addiction, Pain, and Depression: The Search for a Precision Medicine Approach.

Authors:  Michael A Emery; Huda Akil
Journal:  Annu Rev Neurosci       Date:  2020-02-28       Impact factor: 12.449

5.  Opioid use disorder research and the Council for the Advancement of Nursing Science priority areas.

Authors:  Patricia Eckardt; Donald Bailey; Holli A DeVon; Cynthia Dougherty; Pamela Ginex; Cheryl A Krause-Parello; Rita H Pickler; Therese S Richmond; Eleanor Rivera; Carol F Roye; Nancy Redeker
Journal:  Nurs Outlook       Date:  2020-04-09       Impact factor: 3.250

6.  T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice.

Authors:  Xiao-Fei Wang; Elisabeth Barbier; Yi-Ting Chiu; Yi He; Jia Zhan; Guo-Hua Bi; Hai-Ying Zhang; Bo Feng; Lee-Yuan Liu-Chen; Jia Bei Wang; Zheng-Xiong Xi
Journal:  J Neurosci       Date:  2016-10-05       Impact factor: 6.167

7.  Alcohol and Cocaine Exposure Modulates ABCB1 and ABCG2 Transporters in Male Alcohol-Preferring Rats.

Authors:  Alaa M Hammad; Fawaz Alasmari; Youssef Sari; F Scott Hall; Amit K Tiwari
Journal:  Mol Neurobiol       Date:  2018-07-06       Impact factor: 5.590

8.  VMAT2 gene (SLC18A2) variants associated with a greater risk for developing opioid dependence.

Authors:  Matthew Randesi; Wim van den Brink; Orna Levran; Peter Blanken; Jan M van Ree; Jurg Ott; Mary Jeanne Kreek
Journal:  Pharmacogenomics       Date:  2019-04-15       Impact factor: 2.533

9.  Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence.

Authors:  Matthew Randesi; Wim van den Brink; Orna Levran; Peter Blanken; Eduardo R Butelman; Vadim Yuferov; Joel Correa da Rosa; Jurg Ott; Jan M van Ree; Mary Jeanne Kreek
Journal:  Drug Alcohol Depend       Date:  2016-09-05       Impact factor: 4.492

10.  Would You Be Surprised If This Patient Died This Year? Advance Care Planning in Substance Use Disorders.

Authors:  Michelle J Fleshner; Amy J Kennedy; Peter J Veldkamp; Julie W Childers
Journal:  J Gen Intern Med       Date:  2019-08-05       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.